Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Median Technologies Reports 2025 Q1 Key Financial Indicators and Provides an Update on Q1 Key Operational Achievements
Median Technologies Reports 2025 Q1 Key Financial Indicators and Provides an Update on Q1 Key Operational Achievements


Regulatory News:



Median Technologies (FR0011049824, ALMDT, PEA/PME scheme eligible, “Median” or “The Company”), manufacturer of eyonis™, a suite of artificial intelligence (AI) powered Software

Dassault Systèmes and Airbus Extend Strategic Partnership to Use Virtual Twins for Next-Generation Programs
Dassault Systèmes and Airbus Extend Strategic Partnership to Use Virtual Twins for Next-Generation Programs


Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) and Airbus have extended their long-term strategic partnership, putting the 3DEXPERIENCE platform at the heart of lifecycle management of

GenSight Biologics Annual General Meeting on May 13, 2025
GenSight Biologics Annual General Meeting on May 13, 2025


Regulatory News:



GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal

EQS-News: Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones
EQS-News: Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones
EQS-News: Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones
EQS-News: Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors
EQS-News: Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors
EQS-News: Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors
TotalEnergies: Antwerp Platform Adapts to Energy Transition Challenges and Market Trends
TotalEnergies: Antwerp Platform Adapts to Energy Transition Challenges and Market Trends


TotalEnergies’ (Paris:TTE) (LSE:TTE) (NYSE:TTE) Antwerp platform provides an update on its investments for the future and announces plan to reconfigure its petrochemicals operations to strengthen

United States: First Oil From the Ballymore Offshore Field
United States: First Oil From the Ballymore Offshore Field


TotalEnergies announces the start of production from the deepwater Ballymore field offshore U.S., in which the Company has a 40% interest alongside operator Chevron (60%).



Located 120 kilometers

Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 12, 2025
Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 12, 2025


Regulatory News:



Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss

Sensorion to Host a Symposium during ISIET’s International Conference on Inner Ear Therapies on April 26, 2025
Sensorion to Host a Symposium during ISIET’s International Conference on Inner Ear Therapies on April 26, 2025


Regulatory News:



Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss

Sartorius Stedim Biotech publishes unaudited first quarter results for 2025
Sartorius Stedim Biotech publishes unaudited first quarter results for 2025
Sartorius Stedim Biotech publishes unaudited first quarter results for 2025
Liquefied Natural Gas: TotalEnergies will Supply 400,000 Tons of LNG per Year for 15 Years in the Dominican Republic
Liquefied Natural Gas: TotalEnergies will Supply 400,000 Tons of LNG per Year for 15 Years in the Dominican Republic


TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) has signed an agreement (HoA) with Energia Natural Dominicana (ENADOM), the Joint Venture between AES Dominicana and Energas in the Dominican

Liquefied Natural Gas: TotalEnergies to Offtake 1.5 Mtpa of LNG From the Future Train 4 of Rio Grande LNG Facility
Liquefied Natural Gas: TotalEnergies to Offtake 1.5 Mtpa of LNG From the Future Train 4 of Rio Grande LNG Facility


TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) has signed a Sales and Purchase Agreement (SPA) with NextDecade to buy 1.5 million tons per annum (Mtpa) of liquefied natural gas (LNG) from the

Kaufman & Broad SA: 2025, 1ST QUARTER RESULTS
Kaufman & Broad SA: 2025, 1ST QUARTER RESULTS
Kaufman & Broad SA: 2025, 1ST QUARTER RESULTS
GEVELOT S.A.: PRESS RELEASE CLOSING OF 2024 ACCOUNTS
GEVELOT S.A.: PRESS RELEASE CLOSING OF 2024 ACCOUNTS
GEVELOT S.A.: PRESS RELEASE CLOSING OF 2024 ACCOUNTS
PATRIMOINE ET COMMERCE: Q1  2025 RESULTS
PATRIMOINE ET COMMERCE: Q1 2025 RESULTS
PATRIMOINE ET COMMERCE: Q1 2025 RESULTS
Voyageurs du Monde:  Record 2024 results
Voyageurs du Monde: Record 2024 results
Voyageurs du Monde: Record 2024 results
Eutelsat and Panasonic Avionics Agree Multi-Year Extension of Capacity Agreement on EUTELSAT 10B
Eutelsat and Panasonic Avionics Agree Multi-Year Extension of Capacity Agreement on EUTELSAT 10B


Regulatory News:



Eutelsat (ISIN: FR0010221234 - Euronext Paris / London Stock Exchange: ETL) and Panasonic Avionics Corporation (PAC) have announced an extension of their capacity deal on the

GenSight Biologics Announces the Filing of its 2024 Universal Registration Document
GenSight Biologics Announces the Filing of its 2024 Universal Registration Document


Regulatory News:



GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal

GenSight Biologics Reports Cash Position as of March 31, 2025, and Provides Business Update
GenSight Biologics Reports Cash Position as of March 31, 2025, and Provides Business Update


Regulatory News:



GenSight Biologics ("GenSight Biologics" or the "Company") (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing

Verimatrix und AgileTV schließen sich zusammen, um schnell wachsende TVaaS-Lösung zu sichern
Verimatrix und AgileTV schließen sich zusammen, um schnell wachsende TVaaS-Lösung zu sichern


Regulatorische Nachrichten:



Verimatrix, (Euronext Paris: VMX), der führende Anbieter von Sicherheit mit Fokus auf den Menschen für die moderne vernetzte Welt, gab heute eine erweiterte

Verimatrix and AgileTV Partner to Secure Fast-Growing TVaaS Solution
Verimatrix and AgileTV Partner to Secure Fast-Growing TVaaS Solution


Regulatory News:



Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced expanded collaboration with Bilbao

Integrated Power: TotalEnergies Closes Three International Acquisitions of Renewable Portfolios
Integrated Power: TotalEnergies Closes Three International Acquisitions of Renewable Portfolios


Following the agreements signed in 2024, TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) confirms the closing of its acquisitions of VSB Group, a European wind and solar developer with extensive

Eutelsat Ramping up LEO-enabled Aviation Services With High-speed, Low Latency Connectivity
Eutelsat Ramping up LEO-enabled Aviation Services With High-speed, Low Latency Connectivity


Regulatory News:



Eutelsat (ISIN: FR0010221234 - Euronext Paris / London Stock Exchange: ETL) today announced its OneWeb low Earth orbit (LEO) services for commercial and business aviation are now

Sensorion Strengthens Leadership Team with Appointment of Amit Munshi as Chairman of the Board and Independent Director
Sensorion Strengthens Leadership Team with Appointment of Amit Munshi as Chairman of the Board and Independent Director


Regulatory News:



Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL